MHR
MD icon

Matthew Hamilton Rosenberg’s Pediatrix Medical MD Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3
Closed -$28 – 900
2023
Q4 		$28 Hold
3
– – ﹤0.01% 913
2023
Q3 		$38 Hold
3
– – ﹤0.01% 921
2023
Q2 		$43 Buy
+3
New +$42 ﹤0.01% 942

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Matthew Hamilton Rosenberg's MD Position: Q1 2024 in Review

Matthew Hamilton Rosenberg sold out of Pediatrix Medical (MD) in Q1 2024, closing a stake of 3 shares — an estimated $28 sold.

Matthew Hamilton Rosenberg first reported a position in MD in Q2 2023 and held it in 3 quarters. The position peaked at $43 in Q2 2023. 213 funds tracked by Wall St. Rank hold MD as of Q1 2024.

  • Matthew Hamilton Rosenberg reported no remaining Pediatrix Medical position as of Q1 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 3 Pediatrix Medical shares in Q1 2024, an estimated $28.
  • Matthew Hamilton Rosenberg first reported a position in Pediatrix Medical in Q2 2023 and held it in 3 quarters.
  • Matthew Hamilton Rosenberg's Pediatrix Medical position peaked at $43 in Q2 2023.
  • 213 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2024, filed 22 Apr 2024.